Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print September 7, 2005, doi:10.1212/01.wnl.0000176988.87336.ff)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
01.wnl.0000176988.87336.ffv1
65/11/1813    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mikuni, N.
Right arrow Articles by Hashimoto, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mikuni, N.
Right arrow Articles by Hashimoto, N.
Related Collections
Right arrow All Epilepsy/Seizures
Right arrow Epilepsy surgery
Right arrow WADA test
NEUROLOGY 2005;65:1813-1816
© 2005 American Academy of Neurology
Brief Communications

Evaluation of adverse effects in intracarotid propofol injection for Wada test

N. Mikuni, MD, PhD, M. Takayama, MD, T. Satow, MD, PhD, S. Yamada, MD, PhD, N. Hayashi, MD, N. Nishida, MD, J. Taki, MD, R. Enatsu, MD, A. Ikeda, MD, PhD, S. Miyamoto, MD, PhD and N. Hashimoto, MD, PhD

From the Departments of Neurosurgery (Drs. Mikuni, Takayama, Satow, Yamada, Hayashi, Nishida, Taki, Enatsu, Miyamoto, and Hashimoto) and Neurology (Ikeda), Kyoto University Graduate School of Medicine, Kyoto, Japan.

Address correspondence and reprint requests to Dr. Nobuhiro Mikuni, Department of Neurosurgery, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 6068507, Japan; e-mail: mikunin{at}kuhp.kyoto-u.ac.jp

The authors evaluated adverse effects of intracarotid propofol injection during a Wada test and their risk factors in 58 patients. Nineteen patients had an adverse effect, mostly in patients receiving more than 10 mg. For patients older than age 55 years or those requiring an injection dose greater than 20 mg to produce hemiplegia, propofol should be injected slowly and patients monitored for excitatory movements.

Editorial, see page 1692

See also page 1723

This article was previously published in electronic format as an Expedited E-Pub on September 7, 2005, at www.neurology.org.

Supported by Grants-in-Aid for Scientific Research (C2) 14571310 from the Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT).

Disclosure: The authors report no conflicts of interest.

Received March 31, 2005. Accepted in final form June 22, 2005.




This article has been cited by other articles:


Home page
 Br J AnaesthHome page
N. Lao, H. Nie, L. X. Xu, L. Z. Xiong, H. Zhang, Y. Y. Fan, and B. R. Wang
Efficacy of intracarotid propofol infusion and impact of cerebral blood flow alteration
Br. J. Anaesth., February 1, 2009; 102(2): 234 - 239.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. L. Grote and K. Meador
Has amobarbital expired?: Considering the future of the Wada
Neurology, December 13, 2005; 65(11): 1692 - 1693.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.